Related Experiment Video
Updated: Jun 8, 2026
05:12
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Gamma-butyrolactone (GBL) dependence and withdrawal
1King's College London, Addictions Department, Institute of Psychiatry and South London and Maudsley NHS Foundation Trust, Camberwell, London, UK. james.bell@kcl.ac.uk
Addiction (Abingdon, England)
|October 8, 2010
Summary
Gamma-butyrolactone (GBL) dependence causes significant morbidity and social impairment. Ambulatory GBL withdrawal is feasible but requires integrated inpatient support for complex cases.
Area of Science:
- Addiction medicine
- Pharmacology
- Clinical toxicology
Background:
- Gamma-butyrolactone (GBL) dependence is increasingly recognized, presenting challenges in treatment access and management.
- Withdrawal from GBL can lead to significant morbidity, including psychological and physiological distress.
Purpose of the Study:
- To characterize the morbidity associated with gamma-butyrolactone (GBL) dependence.
- To evaluate the outcomes of GBL withdrawal management.
Main Methods:
- A case series design was employed, involving patients seeking detoxification from GBL dependence.
- Out-patient management utilized high-dose diazepam and baclofen, titrated to withdrawal severity, with daily follow-up for three days.
- In-patient care was available for patients requiring a higher level of support.
Main Results:
- Most patients (17/19) were treated as out-patients, with a mean initial diazepam dose of 75 mg.
- Sixteen patients completed withdrawal, though some experienced lapses; one patient developed delirium requiring inpatient transfer.
- Common post-withdrawal symptoms included persistent insomnia, anxiety, and depression.
Conclusions:
- Gamma-butyrolactone (GBL) withdrawal can be effectively managed in ambulatory settings.
- Seamless integration with in-patient detoxification services is crucial for managing severe cases and preventing complications.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:28Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...